EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies

Shubha Bhat iD, Benjamin Click, Miguel Regueiro

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Shubha Bhat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent approval of new medications with novel mechanisms of action and emergence of updated safety information for existing therapies has changed the treatment landscape of inflammatory bowel disease (IBD). These advances led to unique adverse effect profiles and identification of new safety signals, resulting in the evolution of the safety, monitoring, and positioning of IBD therapies. In this updated review, we (1) examine the existing and updated safety data of monoclonal antibodies and small molecules for IBD, with a focus on recently Food and Drug Administration (FDA)-approved therapies, and (2) propose risk stratification and assessment considerations prior to and during IBD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesHumansAntibodies, MonoclonalGastrointestinal AgentsUnited States Food and Drug AdministrationUnited States

Stichwörter der Autor:innen

Crohn’s diseasebiologicsinfectionmalignancysmall moleculeulcerative colitis

Substanzen

Antibodies, MonoclonalGastrointestinal Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Pharmacy, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Shubha Bhat

Zitieren

APA

Bhat, S., Click, B., & Regueiro, M. (2024). Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad120

Vancouver

Bhat S, Click B, Regueiro M. Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad120

BibTeX
@article{Bhat2024,
  author = {Bhat, Shubha and Click, Benjamin and Regueiro, Miguel},
  title = {Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad120}
}
Kostenlos starten →